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1. Introduction 
Interactions between proteins and nucleic acids mediate a wide range of processes within a 
cell from its cycle to the maintenance of cellular metabolic and physiological balance. These 
specific interactions are crucial for control of DNA replication and DNA damage repair, 
regulation of transcription, RNA processing and maturation, nuclear transport, and 
translation. 
The characterization of protein-nucleic acid interactions is essential not only for 
understanding the wide range of cellular processes they are involved in, but also the 
mechanisms underlying numerous diseases associated with the breakdown of regulatory 
systems. These include, but are far from being limited to, cell cycle disorders such as cancer 
and those caused by pathogenic agents that rely on or interfere with host cell machinery.  
More recently, it has been hypothesized that many neurological disorders such as 
Alzheimer’s, Huntington’s, Parkinson’s, and polyglutamine tract expansion diseases are a 
consequence, at least in part, of aberrant protein-DNA interactions that may alter normal 
patterns of gene expression (Jiménez, 2010). 
The electrophoretic mobility shift assay (EMSA), also known as gel retardation assay, is a 
regularly used system to detect protein-nucleic acid interactions. It was originally developed 
with the aim of quantifying interactions between DNA and proteins (Fried & Crothers, 1981; 
Garner & Revzin, 1981) and since then evolved to be suitable for different purposes 
including the detection and quantification of RNA-protein interactions. EMSA is most 
commonly used for qualitative assays including identification of nucleic acid-binding 
proteins and of the respective consensus DNA or RNA sequences. Under proper conditions, 
however, EMSA can also be used for quantitative purposes including the determination of 
binding affinities, kinetics, and stoichiometry. 
EMSA is a commonly used method in the characterization of transcription factors, the most 
intensely studied DNA-binding proteins, and the largest group of proteins in humans, 
second only to metabolic enzymes. Their purification and identification is crucial in 
understanding gene regulatory mechanisms. Transcription factors are sequence specific 
DNA binding proteins that are usually assembled in complexes formed prior to 
transcription initiation. They bind discreet and specific DNA sequences in the promoter 
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region functioning either as an activator or repressor of expression of the targeted gene 
through protein-protein interactions (reviewed by Simicevic & Deplancke, 2010). 
Transcription factors play essential roles during development and differentiation. It is well 
established that disruption of normal function of tissue-specific transcription factors, as a 
result of mutations, is often associated with a number of diseases including most forms of 
cancer, neurological, hematological, and inflammatory diseases. Additionally, transcription 
factors are often found differentially expressed in different pathologies suggesting an at 
least indirect involvement on the onset or progression of diseases. One of the most 
prominent examples of the involvement of transcription factors in development and 
progression of diseases is perhaps the p53 protein. p53 is a transcription factor involved in 
the modulation of expression of several genes that regulate essential cellular processes such 
as cell proliferation, apoptosis, and DNA damage repair (reviewed by Puzio-Kuter, 2011). 
Mutations in p53 that cause loss of function were reported in about 50% of all cancers. It is 
believed that this loss of function makes cancer cells more prone to the accumulation of 
mutations in other genes thus facilitating and accelerating the formation of neoplasias 
(reviewed by Goh et al., 2011). 
In our laboratory, research is mainly directed to the study of host-pathogen interactions 
during hepatitis delta virus (HDV) replication and infection. HDV is the smallest human 
pathogen so far identified and infects human hepatocytes already infected with the 
hepatitis B virus (HBV). Both viruses have the same envelope proteins that are coded by 
the HBV DNA genome. HDV is, thus, considered a satellite virus of HBV. The HDV 
genome consists of a single-stranded, circular, RNA molecule of about 1700 nucleotides. 
This genome contains only one open reading frame from which two forms of the same 
protein, the so-called delta antigen, are derived by an editing mechanism catalyzed by 
cellular adenosine deaminase I. Both forms, small and large delta antigen, were shown to 
play crucial roles during virus replication: the small delta antigen is necessary for virus 
RNA accumulation and the large delta antigen plays an important role during envelope 
assembly (reviewed by Rizzetto, 2009). However, neither protein seems to display any 
known enzymatic activity. Accordingly, HDV is highly dependent on the host cell 
machinery for virus replication. It has been shown through EMSA that the small delta 
antigen binds in vitro to RNA and DNA without any specificity, which is in agreement 
with one of the roles attributed to the protein as a chaperone (Alves et al., 2010). Making 
use of different experimental approaches it was possible to identify a number of cellular 
proteins that interact with HDV antigens or RNA (reviewed by Greco-Stewart & Pelchat, 
2010). However, the precise role played by most host factors during the virus life cycle 
remains elusive. Furthermore, it is highly consensual among HDV researchers that many 
other cellular factors that interact with delta antigens or HDV RNA remain to be 
identified and it is crucial to find those that interact with HDV RNA for a better insight on 
its replication and as possible targets for new therapies. 
In this chapter we will review the principles of EMSA and its advantages and limitations for 
the quantitative and qualitative analysis of protein-nucleic acid interactions. The key 
parameters influencing the quality of protein samples, binding to nucleic acids, complex 
migration in gels, and sensitivity of detection will be discussed. Finally, an overview of the 
principles, advantages and disadvantages of methods that are an alternative to gel 
retardation assays will be provided. 
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2. Advantages and limitations 
Since its first publication, in 1981, several improvements and variant techniques of EMSA 
were reported. Originally described as a method to qualitatively detect protein-DNA 
interactions, gel retardation assays rapidly became one of the most popular methods to map 
interaction sequences and domains not only in DNA but in RNA-protein interactions as 
well. EMSA was also adapted in order to allow the determination of quantitative parameters 
including complex stoichiometry, binding kinetics and affinity. 
Several features made EMSA one of the most popular methods among researchers that 
study protein-nucleic acid interactions. Probably, the main advantages of EMSA when 
compared to other methods, as we will further discuss in the next sections, may be 
considered as follows: (1) EMSA is a basic, easy to perform, and robust method able to 
accommodate a wide range of conditions; (2) EMSA is a sensitive method, using 
radioisotopes to label nucleic acids and autoradiography, it is possible to use very low 
concentrations (0.1nM or less) and small sample volumes (20 µL or less; Hellman & Fried, 
2007).  Even though, less sensitive, non-radioactive labels are often used as well. These 
labels can further be detected using fluorescence, chemiluminescence or 
immunohistochemical approaches. Although less sensitive then radioisotopes, the wide 
variety of labels that can be used makes EMSA a very versatile method; (3) EMSA can also 
be used with a wide range of nucleic acid sizes and structures as well as a wide range of 
proteins, from small oligonucleotides to heavy transcription complexes; (4) Under the right 
conditions a gel retardation assay can separate the distribution of proteins between several 
nucleic acids within a single sample (Fried & Daugherty, 1998) or distinguish between 
complexes with different protein stoichiometry and/or binding site distribution (Fried & 
Crothers, 1981); (5) Finally, but not less important, it is possible to use both crude protein 
extracts and purified recombinant proteins enabling the identification of new nucleic acid-
interacting proteins or characterization of specific proteins and its targets. 
Despite its sensitivity, versatility and usually easy to perform protocols, EMSA is often 
considered to bear a number of limitations. Dissociation can occur during electrophoresis 
since samples are not at equilibrium during the run, thus preventing detection. 
Additionally, complexes that are not stable in solution may be stable in the gel requiring 
very short runs so that the observed pattern relates to what happens in solution. EMSA does 
not provide a straightforward measure of the weights or entities of the proteins as mobility 
in gels is influenced by several other factors. Also, EMSA does not directly provide 
information on the nucleic acid sequence the proteins are bound to. However, this problem 
may usually be overcome using footprinting approaches as described further ahead. Kinetic 
studies using EMSA are limited since the time resolution for a regular EMSA protocol 
consists of the time required to mix the binding reaction and for the electrophoretic 
migration to occur before the mix enters the gel. Only processes that have relaxation times 
larger than the interval required for solution handling are suitable for kinetic studies. 
3. How complexes migrate in gels 
In this section, we will start with a simple account of the characteristics of the 
electrophoretic mobility of nucleic acids alone, and afterwards we will discuss how the 
formation of protein-nucleic acid complexes alters these characteristics. 
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In a non-denaturing agarose or polyacrylamide gel and conventional buffer conditions the 
nucleic acids, being negatively charged, will migrate towards the anode when electric 
current is applied. The gel will then act as a sieve selectively impeding the migration in 
proportion to the nucleic acid molecular weight, which is generally proportional to its 
charge. Therefore, and as the weight is approximately related to chain length, the length of 
nucleic acid is estimated by its migration. There is though another property that affects gel 
migration that is the topology of the nucleic acid (conformation, circularity) making the 
molecules seem longer or shorter than they really are. Secondary and tertiary structures can 
be removed using denaturing agents (for example, formaldehyde, formamide and urea) 
allowing for the electrophoretic mobility to become a simple function of molecular weight. 
Obviously, this denaturing step cannot be applied in a gel retardation assay as it would 
impede the interaction between the protein and nucleic acid. 
 
Fig. 1. Example of an electrophoretic mobility shift assay. An unlabeled DNA of 400 base 
pairs (bp) was incubated in a phosphate buffer (137mM NaCl, 2.7mM KCl, 4.3mM 
Na2HPO4, 1.5mM KH2PO4, pH 7.4) in the absence (1) or presence (2) of 2µM of small  
delta antigen. The samples were loaded onto a 1.5% agarose gel and after electrophoresis  
in TAE buffer (40mM Tris acetate, 1mM EDTA) the DNA was stained with ethidium 
bromide. (M) represents the molecular weight marker (GeneRuler DNA Ladder mix, 
Fermentas). 
When a protein is added to the mix and interacts with the nucleic acid forming complexes it 
results in a change in gel migration relative to that of the free nucleic acid. This shift is 
mainly due to an obvious increase in the molecular weight, the adjustment of charge and 
eventual changes in the nucleic acid conformation. In figure 1 we give an example of an 
EMSA study where the small delta antigen was added to DNA. It is clear that the addition 
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of the small delta antigen (Fig.1. well 2) to a 400bp DNA fragment results in the formation of 
a complex with decreased gel mobility when compared with the unbound DNA (Fig.1. well 
1). We can conclude that under our in vitro binding conditions, the small delta antigen 
interacts with the given 400bp DNA fragment causing a clear mobility shift. 
It is expected that when protein binds a nucleic acid fragment there will be a decrease in 
relative mobility and if the protein doesn’t induce any appreciable bend on the nucleic acid 
then the conformational contribution to the decrease is small. Although an increase in the 
protein molecular weight results in reduction of gel migration it has been reported that the 
increase of the nucleic acid length can have the opposite effect. This was reported for the Lac 
repressor bound to DNA fragments of increasing sizes, which resulted in an increase of 
relative mobility (Fried, 1989). This observation indicates that the ratio of protein and 
nucleic acid weights is more important in the migration than the absolute weight of the 
complex. Another interesting study reports that the binding of protein to a nucleic acid can 
accelerate mobility. This was observed for relatively large linear DNA binding to a protein 
from the hyperthermophilic Methanothermus fervidus that was shown to induce nucleic acid 
condensation (Sandman et al., 1990). In this case the conformational change of the DNA is a 
stronger factor than the weight increase, causing acceleration rather than a decrease in 
relative mobility. 
Overall, the conformational features that influence gel migration of protein-nucleic acid 
complexes are not thoroughly studied and questions are only raised when exceptions 
emerge such as the ones mentioned above. Nowadays, the EMSA method is almost 
exclusively used to analyze the interaction between proteins and nucleic acids and to a 
lesser extent its conformations that can influence gel migration. When exceptions arise and 
the retardation pattern is not exactly as predicted, it can still point out clearly whether the 
molecules are interacting or not. In the end, the exact location of the resulting gel bands 
cannot be predicted but the answer is usually unambiguous. 
External factors can also influence the separation of the bound or unbound nucleic acid such 
as the nature of the gel matrix and temperature during electrophoresis. Generally, the best 
resolution is obtained with the smallest pore diameter that allows the migration of unbound 
nucleic acid. However, if large complexes are expected there should be a compromise in 
pore size so that they can enter the gel matrix. As will be discussed below, polyacrylamide 
gels offer the best conditions for small complexes and nucleic acid fragments. On the other 
hand, agarose gels are more suitable for larger aggregates. 
The detection of a protein-nucleic acid complex within a gel depends critically on the 
resolution obtained between unbound nucleic acid and the formed complexes as well as its 
stability within the gel matrix. In most cases, the gel matrix is expected to stabilize the 
preformed complex as it impedes the diffusion of dissociating components maintaining the 
concentration of protein and nucleic acid (and complex) at levels as high or higher than 
those achieved in the equilibrium binding reaction. This of course is compromised if for 
instance the salt concentration in the binding reaction differs largely from that in the 
electrophoresis/gel buffer, resulting in an adjustment in salt concentration that could 
disrupt the complexes formed. As the gel retardation method is an in vitro assay, when 
extrapolating to the in vivo conditions one must be careful as the former may provide 
favorable binding conditions that are not achieved at physiological concentrations. 
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4. The method 
There are five focal steps in a conventional EMSA protocol that involve different variables 
susceptible to optimization: (1) preparation of protein sample; (2) synthesis and labeling of 
nucleic acid; (3) binding reaction; (4) non-denaturing gel electrophoresis and (5) detection of 
the outcome. In this segment we will discuss each step separately mentioning the key 
variables in each one and the options available for any given situation. Figure 2 represents 
schematically the regular steps in a gel retardation assay that will be discussed below. 
Whenever possible we will also refer to examples in the literature. 
 
Fig. 2. A schematic representation of a conventional  EMSA protocol. The labeled nucleic 
acid, simplified as lines with a star representing the label, is mixed with the protein sample, 
represented by the oval shapes, in a binding reaction and then loaded into a non-denaturing 
gel. After electrophoresis the result is detected according to the label in the nucleic acid. On 
the schematic gel (A) represents a well on which only the labeled nucleic acid was loaded. 
The free nucleic acid is expected to have more mobility than the bound molecules. In well 
(B) is symbolized a labeled nucleic acid binding to one small peptide and in well (C) is 
binding to two larger proteins. The heavier complex (in C) is expected to display the lowest 
mobility during electrophoresis and therefore is closer to the beginning of the gel.  
4.1 Preparation of the protein sample  
Regarding the protein sample, the EMSA can be divided into two categories based on 
whether the nucleic acid-interacting protein is known or not. Therefore, preparing the 
protein sample will depend on which category it falls, in order to obtain an optimal 
performance. 
When faced with a putative nucleic acid-binding protein or complex of completely 
unknown subcellular origin, whole cell extracts must be used. If there is an educated guess 
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on the nature of the protein, it is advisable to isolate nuclear and cytoplasmic proteins from 
crude extracts improving the results. Particularly, if the binding protein is thought to be 
nuclear and in low abundance, the isolation of nuclear extracts will prevent the dilution that 
would occur if whole cell extracts were used, which could render the concentration too low 
for the protein to be even detected.  
Cell extracts are easy and relatively fast to obtain and the methods are commonly derived 
from the protocol described by Dignam and collaborators almost three decades ago 
(Dignam et al., 1983). This method isolates both nuclear and/or cytoplasmic proteins 
suitable for later analysis using EMSA. One disadvantage in preparing cell extracts is its 
crudeness; they generally degrade faster than purer preparations due to the presence of 
cellular proteases. To limit protein degradation or alteration the protocol should be 
performed on ice or at 4ºC and protease inhibitors should be added. A control test can easily 
be performed to assess the viability of the extract by using ubiquitous DNA probes (Kerr, 
1995). If these fail than the cell extract might be “dead”. Despite its disadvantages cell 
extracts are needed when the interest lies in identifying new nucleic acid-binding proteins 
or when a complex of different proteins is needed to interact with the target nucleic acid as 
sometimes one recombinant protein cannot bind by itself. Tissue samples can also be a 
source of protein sample for these assays. The same care should be taken as in whole cell 
extracts to minimize the activity of proteases. 
If the nucleic acid-binding protein is known then recombinant proteins can be expressed 
and purified. Recombinant or heterologous proteins are commonly expressed in bacteria or 
an eukaryotic cell line of interest. Fusion proteins of the target are generally constructed 
with a tag to facilitate purification. Common tags, such as glutathione-S-transferase (GST), 
tandem affinity purification tag (TAP tag), maltose binding protein (MBP) or 6xHistidine, 
are cloned in frame with the protein. Sometimes it is possible to include a protease cleavage 
site between the protein of interest and the tag so the latter can be easily removed after 
purification. Even though a tag can be very helpful, it should be taken into account that it 
can alter the recombinant protein conformation and even disrupt its binding ability. On the 
other hand they can be helpful in stabilizing the protein terminus they are close to. A careful 
study is needed when choosing the tag and usually small peptides are preferred to 
minimize its impact on the recombinant protein of interest. 
There are several systems available for the production of heterologous proteins of which 
bacterial extracts of Escherichia coli are one of the most widely used. This Gram-negative 
bacterium remains an attractive host due to its ability to grow rapidly and with  
high density using inexpensive substrates. Its genetics has been well characterized for 
quite some time and there is a wide range of cloning vectors as well as mutant host strains 
that make it such a versatile system. Typically, the heterologous complementary DNA  
is cloned into a compatible plasmid which is then transfected into the bacteria to achieve  
a high gene dosage. This doesn’t necessarily guarantee the accumulation of high levels  
of a full-length active form of the recombinant protein but other efforts can be made  
to improve that. To achieve high-level production in E. coli strong promoters should  
be used such as the bacteriophage T7 late promoter, and usually the T7 polymerase is  
also present under IPTG (isopropyl-β-D-1-thiogalactopyranoside)-induction. In the past 
years several strains have been engineered to improve the recombinant protein  
yields through efforts to increase mRNA stability as well as improve transcription 
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termination and translational efficiency (reviewed by Baneyx, 1999 and Makino et al., 
2011). However, this extensively used system for protein overexpression has an important 
drawback when studying eukaryotic proteins. The bacterial systems are not able to 
perform post-translational modifications that would eventually happen in vivo in 
eukaryotic cells. 
When working with recombinant nucleic acid-binding proteins it should be taken into 
account the importance of post-translational modifications on the protein’s binding ability. 
A careful research of previous reports might hint if it is necessary to perform modifications 
prior to the binding reaction. In some cases post-translational modifications change the 
sequence-specificity of the binding. For example, genotoxic stress induces modifications on 
the C-terminus of the tumor suppressor protein p53 that modulate its DNA-binding 
specificity (Apella & Anderson, 2001). If the modifications are crucial, rather than using 
bacterial extracts a more biologically relevant host should be considered. Transient gene 
expression in mammalian cells has become a routine approach to express proteins in cell 
lines such as human embryonic kidney cells. The benefits are obvious for the production of 
eukaryotic proteins in mammalian cells as post-translational modifications will likely be 
native or near-native, solubility and correct folding are more likely to occur as well as 
expression of proteins in their proper intracellular compartments. These methods, however, 
tend to be more expensive as cells need a more complex growth media and there is a lower 
diversity in cloning vectors. To get out of the latter limitation an alternative approach uses 
baculovirus-infected insect cells. In this method a recombinant virus is produced either by 
site-specific transposition of an expression cassette into the shuttle vector or through 
homologous recombination (reviewed by Jarvis, 2009).  
When expressing recombinant proteins, sometimes, the heterologous genes interfere 
severely with the survival of the host cell. For toxic proteins produced in E. coli strains there 
are some techniques available to get around this problem. A highly toxic gene can be 
defined as a gene that, when introduced into a cell, causes cell death or severe growth and 
maintenance defects even prior to expression induction. The best solution for expressing a 
highly toxic gene is to enable the host to tolerate it during the growth phase, so that after 
induction an efficient expression ensures a rapid and quantitative production of the toxic 
protein before the cell dies (reviewed by Saida et al., 2006). This can be achieved by different 
strategies such as manipulation of the gene’s transcriptional and translational control 
elements, for example, by suppressing basal expression of the toxic protein from leaky 
inducible promoters. Managing the coding sequence to produce reversible inactive forms or 
controlling the plasmid copy number is also an option as well as selecting less susceptible E. 
coli strains or adding stabilizing sequences. 
Cell-free systems are also available to express recombinant proteins including in vitro 
transcription\translation systems such as rabbit reticulocyte systems, wheat germ based 
systems or E. coli cell-free protein expression systems (reviewed by Endo & Sawasaki, 
2006). Here, proteins can be expressed directly from cDNA templates obtained  
through PCR, avoiding subcloning which makes it a faster method by skipping this step, 
and eventually cheaper. It can also be used to express proteins that seriously interfere 
with the cell physiology such as the toxic proteins mentioned above. On the other hand 
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4.2 Synthesis and labeling of nucleic acids  
One of the key advantages of EMSA is its versatility as it can be performed using a wide 
range of nucleic acid structures and sizes. This method can characterize both double- and 
single-stranded DNA as well as RNA, triplex and quadruplex nucleic acids or even circular 
fragments. The probe design and synthesis depends on the application or purpose of the 
study and is a significant aspect, as it will influence the detection and therefore the 
sensitivity of the results. There are two main aspects to consider in this step: the length of 
the nucleic acid and its labeling. 
Unlabeled nucleic acids can be used in a gel retardation assay and be detected by post-
electrophoretic staining with chromophores or fluorophores that bind nucleic acids or in the 
“classical way” using ethidium bromide. However the use of labeled nucleic acids is usually 
preferred as it can facilitate detection and add sensitivity to the method. The most common 
choice is radioisotope labeling as it offers the best sensitivity without interfering with the 
structure of the probe. A higher sensitivity makes it ideal for assays that have a limited 
amount of starting material. The radioisotope, usually 32P, can be incorporated in the nucleic 
acid during its synthesis, by the use of labeled nucleotides, or afterwards via end labeling 
using a kinase or a terminal transferase. With a radioactive label the EMSA results can be 
easily detected by autoradiography. Even if radioisotope labeling confers high sensitivity to 
the method it implies handling hazardous radioactive material requiring extra safety 
measures that may not be available. Other labels can be used as alternatives that, even 
though are less sensitive, are a lot safer to manipulate and more stable such as fluorophores, 
biotin or digoxigenin (Holden & Tacon, 2011). When these molecules are used detection is 
achieved by chemiluminescence or immunohistochemistry. Although, in general 
radioisotope labeling achieves higher sensitivity there are some reports that similar results 
can be obtained with other labels such as Cyano dye Cy5 (Ruscher et al., 2000). 
Although the most common approach is the labeling of the nucleic acid probe there are 
protocols available that employ protein labeling at the same time. For example, Adachi and 
co-workers suggest the use of an iodoacetamide derivative labeling of the thiol residue of 
cysteins (Adachi et al., 2005). Using radioisotope labeled DNA mixed with a nuclear protein 
extract they perform a conventional EMSA and after detection by autoradiography the 
complexes are eluted from excised gel bands and treated with 5-iodoacetamidofluorescein 
for protein labeling. The sample is then loaded onto a denaturing gel and after 
electrophoresis is transferred to a membrane and detected with anti-fluorescein antibody. 
This allows the characterization of the proteins in the complex giving information on how 
many proteins are present and their molecular weight. However it is not able to detect 
proteins without cystein residues.  
Regarding the length of the nucleic acid probe, it depends on what is being studied. If one is 
looking for specific binding sites, small probes can be used to assess with each segment the 
protein will interact. The use of short nucleic acids has several advantages as they are easily 
synthesized and inexpensive to purchase; a small sequence has less non-specific binding 
sites (it should be particularly advantageous when a protein has low sequence-specificity); 
the electrophoretic resolution between complexes and free nucleic acid is higher so shorter 
electrophoresis times can be used. Nevertheless, in a short sequence the binding sites are 
closer to the molecular ends which can cause aberrant binding and it can be tricky to resolve 
the free nucleic acid from the complexes formed if these have a very high molecular weight. 
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On the other hand, the longer nucleic acid targets avoid these problems but will have more 
non-specific binding sites and the mobility shift is generally smaller requiring longer 
electrophoresis times as they run more slowly. A compromise needs to be reached 
depending on what the EMSA study is trying to achieve. 
4.3 Binding reaction  
The interaction between proteins and nucleic acid is sensitive to salt concentration and pH 
as it will influence the protein charge and conformation. However, the experimental 
conditions are very versatile in that different buffers can achieve good results. The most 
commonly used are Tris based buffers but other options include 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 3-(N-morpholino)-propanesulfonic acid (MOPS), 
and glycine or phosphate buffers. Naturally, it is advisable to provide an environment as 
close as possible to physiological conditions so the data obtained in vitro can be related to 
what happens in vivo.  
Additives can be included in the binding reaction either if the interactions require the 
presence of co-factors or stabilizing agents, or as helpful components to minimize non-
specific binding. Glycerol or other small neutral solutes, for example sucrose, can be  
added to the binding mixture to stabilize labile proteins or enhance the stability of the 
interaction (Vossen et al., 1997). These solutes are used at final concentrations of 2M or less, 
as higher concentrations might interfere with the sample’s viscosity and complicate 
handling. Other assays may require the presence of co-factors for a correct interaction such 
as the presence of cAMP for the E. coli CAP protein (Fried & Crothers, 1984) or ATP for 
human recombinase Rad51 (Chi et al., 2006). Non-ionic detergents are used to maximize 
protein solubility. In this case, the concentrations used depend on the detergent and system 
under study. Nuclease and phosphatase inhibitors can be useful as well as protease 
inhibitors, which as mentioned before, are particularly important when the protein sample 
comes from cell extracts. These inhibitors are commercially available and the concentration 
depends on the manufacturer’s instructions. Some of the additives mentioned, particularly 
those involved in stabilizing the formed complexes can be included not only in the binding 
mixture but also in the gel buffers.  
To minimize non-specific loss of protein the addition of a carrier protein (less than 
0.1mg/mL) such as bovine serum albumin can be very helpful. The addition of unlabeled 
competing nucleic acids is suitable when there are secondary binding activities that mask 
the relevant one. Of course this only works if the protein interacts with the target nucleic 
acid with greater affinity then its competitor and the secondary binding does not 
discriminate between the sequences. Since the presence of a competing nucleic acid will 
always reduce the amount of specific binding, testing different competitors and 
concentrations is needed to optimize the assay. Another option to circumvent the problem 
of non-specific binding is the addition of salt at concentrations that will disrupt non-specific 
ionic bonds but leave the more specific interactions unimpaired. 
4.4 Non-denaturing gel electrophoresis  
After the binding reaction the free nucleic acid is separated from the formed complexes by 
non-denaturing gel electrophoresis. EMSA can be performed on polyacrylamide or agarose 
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gels depending mainly on the size of the nucleic acid and desired resolution. The average 
pore size is estimated to be around 5 to 20nm in diameter for 10 and 4% acrylamide gels 
respectively (Lane et al., 1992). Typically the higher concentration gels are used for 
oligonucleotides and small RNAs and the lowest concentration for DNA fragments of 
around 100bp. A polyacrylamide gradient gel is sometimes preferred over linear gels as the 
gradient in pore size increases the range of molecular weight fractioned in a single run, 
which is particularly important when the complex has a much higher weight than the free 
nucleic acid (Walker, 1994). When complexes of different composition are formed, the 
gradient gels are also more likely to separate those with close molecular weight. 
Agarose gels, on the other hand, have a pore size of around 70 to 700nm (Lane et al., 1992) in 
diameter and are therefore mostly used in assays with larger nucleic acid fragments or when 
large protein complexes are expected.  Overall, polyacrylamide gels offer a better resolution 
for nucleic acid-protein complexes with a molecular weight of up to 500,000Da (Fried, 1989 
as cited in Hellman & Fried, 2007). 
Regarding the electrophoresis buffers, it should be taken into account the fact that the 
interaction between nucleic acids and proteins involves an ionic component. Therefore, the 
buffer’s ionic strength and pH are important features that play a role in the complex 
stability. Although this is a very important factor there hasn’t been, to our knowledge, any 
thorough study on the subject. The choice of electrophoresis buffers is varied and generally 
low ionic strength buffers are preferred and sometimes coincide with the buffer used in the 
binding reaction. Buffers with a medium salt concentration help stabilize the complexes, 
generate less heat during electrophoresis and also increase the speed of migration. High salt 
concentrations not only disrupt the complexes but also interfere with its movement into the 
gel matrix and lead to significant heating during the electrophoresis. Too low salt 
concentrations can also disrupt the stability of the preformed complexes as well as separate 
a double stranded DNA template (Kerr, 1995). The most common buffers are TBE (90mM 
Tris-Borate, 2mM EDTA, pH 8) and TAE (40mM Tris-Acetate, 1mM EDTA, pH 8). However, 
there are some complexes that cannot be detected with the classical buffers. For example the 
complexes formed between phage Mu repressor and its operators have an electrophoresis 
buffer-dependent stability and require Tris-glycine buffer at pH 9.4. (Alazard et al., 1992 as 
cited in Lane et al., 1992).  
Particularly, in agarose gels it is important to monitor the temperature during 
electrophoresis to prevent the gel from heating up which could result in dissociation of the 
nucleic acid-protein complexes. Some cases may require that pre-cooling of the gel or even 
that the electrophoresis proceeds at lower than room temperatures, which can be achieved 
with special refrigeration devices. 
4.5 Detection 
The detection of an EMSA result will naturally depend on the labels used if any has been 
used. The results uncovered can involve the detection of the mobility shift between free 
nucleic acid and the complexed form or the detection of the mobility shift of free protein and 
the complexes. 
Looking at the nucleic acid component without any label added the shift in mobility can be 
detected by staining with molecules that bind nucleic acids. Different products can be used 
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ranging from the classic but hazardous ethidium bromide to other chromophores or 
fluorophores such as RedSafe DNA Stain (ChemBio) or SYBR® Safe DNA gel stain 
(Invitrogen). When the nucleic acid has been previously labeled the detection methods 
depend on the nature of the label. A 32P radioisotope is one of the easiest and most sensitive 
methods to detect nucleic acids but it’s a hazardous material to work with. Other very 
common labels are biotin, digoxigenin or fluorophores. These labels are innocuous but 
usually give less sensitive results and the detection procedure can involve extra steps such 
as transfer to a membrane and incubation with primary and secondary antibodies as well as 
intermediate washing steps. The results in these cases can be observed by 
immunohistochemistry or chemiluminescence approaches.  
The detection of protein mobility shift involves less direct methods, meaning, extra steps 
such as a denaturing step and electrotransfer onto a membrane, may be necessary as they 
are usually immunodetected. If the protein of interest is known, and a specific antibody is 
available, it can be used in detection. If not, a method such as the one discussed above, 
proposed by Adachi and colleagues that involves labeling the thiol group of cysteins and 
using an antibody against the label. Stepwise, the easier way to detect protein in an EMSA is 
by labeling it with radioisotope, a method designated by reverse EMSA that will be 
discussed ahead. This procedure has the disadvantage of working with radioactive material 
but the mobility shift can be visualized by autoradiography. 
5. EMSA applications 
The gel retardation assay has been used under different conditions in order to achieve 
specific results. The method is useful in studying not only the interaction between proteins 
and nucleic acids but also in assessing nucleic acid conformational characteristics. It can be 
used to characterize bends in the DNA double helix with polyacrylamide gels and 
comparative measurements (for an example Crothers & Drak, 1992) or to detect complexes 
formed with super coiled DNA being sometimes designated as topoisomer gel retardation 
(for examples see Palecek, 1997;  Nordheim & Meese, 1988). In this section we mention how 
a gel retardation assay can help characterize protein-nucleic acid interactions.  
5.1 Binding constants 
Although EMSA is most commonly used as a qualitative assay it can, under certain conditions, 
provide quantitative data for relatively stable complexes. One of its earliest applications was in 
the measurement of kinetic and thermodynamic parameters. The association rates are 
determined by mixing the complex components at known concentrations and loading them in 
a running gel at precise intervals (for an example Spinner et al., 2002). For dissociation rates, a 
time course experiment is done by addition of competing nucleic acid to the preformed 
complexes (Fried & Crothers, 1981). The binding constant can be determined by the amount of 
complex formed as a function of protein concentration at equilibrium or as a ratio of the 
association and dissociation constants (for an example Demarse et al., 2009). An alternative 
method to measure kinetic and thermodynamic constants is the nitrocellulose filter binding 
assay that will be mentioned below. 
As an example we show in figure 3 the titration of a DNA with the small delta protein to 
assess binding constants. The binding reaction was done by incubating the samples in a 
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phosphate buffer during the same period of time (10 minutes) and then loading them onto 
an agarose gel for electrophoresis. It is clear that when the protein is present at only 0.25µM 
it does not interfere with the DNA mobility (Fig.3. well 2) as the band covered the same 
distance as the first sample, in which the protein was not present (Fig.3. well 1). But when 
1.5µM of the small delta antigen are present in the binding reaction there is almost no free 
DNA present and the majority of the molecules are bound in a complex (Fig3. well 5). In the 
intermediate concentrations it can be clearly observed the decreasing presence of free DNA 
and increasing DNA-protein complexes as the protein concentration raises. We can consider 
that the dissociation constant can be estimated by quantifying the disappearance of the free 
DNA band (Demarse et al., 2009). From figure 3 we can say that the apparent dissociation 
constant is between 1 and 1.5µM. 
 
Fig. 3. Titration of a 500bp DNA fragment with the small delta antigen to estimate binding 
constants. An unlabeled 500bp DNA complementary to part of the HDV RNA was 
incubated, in a phosphate buffer (137mM NaCl, 2.7mM KCl, 4.3mM Na2HPO4, 1.5mM 
KH2PO4, pH 7.4), with increasing concentrations of small delta antigen of 0; 0.25; 0.5; 1; 
and 1.5µM and samples were loaded onto wells 1, 2, 3,4  and 5, respectively. 
Electrophoresis was in a 1.5% agarose gel in TAE buffer and the DNA was stained with 
ethidium bromide. 
5.2 Cooperativity 
Proteins can bind nucleic acids in a cooperative manner, that is, the complexes formed 
involve the binding of more than one protein to a specific nucleic acid segment. These 
multiprotein complexes may be a consequence of direct protein-protein interaction needed 
for nucleic acid binding, or a protein-induced deformation of the nucleic acid is a 
prerequisite to facilitate the binding of a second protein, or it may result from the bringing 
together of molecules bound at distinct sites in the nucleic acid sequence. The cooperativity 
can be inferred in a gel retardation assay from the underrepresentation of intermediate 
complexes between the unbound and saturated states. Multiprotein complexes can be 
comprised of a single protein species forming a homomultimer or of different proteins. The 
latter can be easily characterized by EMSA by the stability of the complexes formed with 
one protein in the presence or absence of the other(s).  
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Determining the important parameter that is stoichiometry is not as easy a task as it seems. 
The apparent weight changes estimated from the complexes’ gel mobility are not applicable 
in determining the stoichiometry due to complications of charges and conformational  
effects on gel migration. A different approach is needed. The presence of truncated or 
extended protein derived from the wild-type but with the same binding and 
multimerization capacity will originate new bands that can reflect the monomers bound to 
the nucleic acid (Hope & Struhl, 1987). A similar method that will be discussed in the next 
segment is the supershift EMSA that uses an antibody specific for the binding protein 
recognizing an epitope that is accessible while the protein is bound to the nucleic acid. The 
addition of the antibody to the preformed complex can provide an estimate of the number of 
proteins bound by the extent of increments in retardation (Michael N & Roizman B, 1991 as 
cited in Lane & Prentki, 1992). 
A more complex approach has been proposed in 1988 to determine a complex’s 
stoichiometry (Granger-Schnarr et al., 1988). After the separation of the free and the 
complexed nucleic acid on a non-denaturing gel, the proteins are transferred to a membrane 
after sodium dodecyl sulfate (SDS) denaturation. This then allows the detection of proteins 
directly or indirectly using a specific antibody. The protein bands as well as the nucleic acids 
autoradiograph are then quantified by densiometry and the relative stoichiometry can be 
determined. The need for a specific antibody limits this method to complexes formed by 
well known proteins with available antibodies. 
6. EMSA variants 
Over the years variations or coupling of the EMSA protocol with other methods has been 
proposed to enhance its results or obtain more information from one experiment. Some 
examples of these EMSA-based approaches will be presented. 
6.1 Reverse EMSA (rEMSA) 
A reverse EMSA consists in labeling the protein sample rather than the nucleic acid  
(Filion et al., 2006). This method shows the difference in mobility between the free  
protein and nucleic acid-bound protein. It is an approach that can facilitate the 
determination of the protein binding affinity using different nucleic acids. Because the label 
used is 35S instead of 32P it is less sensitive than the conventional EMSA due to the isotope’s 
energy. 
6.2 Supershift EMSA 
The supershift EMSA uses the same protocol as a regular EMSA except in that an antibody 
against the binding protein is added. As a result there is a more marked mobility shift 
during electrophoresis because the antibody will increase the overall complex molecular 
weight, hence the term supershift. This method can help identify if the proteins present in 
the complex have a specific epitope and is also used to validate previously identified 
proteins. It can also improve resolution when the difference between free nucleic acid and 
the complex is very small. 
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6.3 Multiplexed competitor EMSA (MC-EMSA) 
The multiplexed EMSA was developed in 2008 by Smith and Humphries to characterize 
nuclear protein and DNA interactions, namely with transcription factors. In this method the 
nuclear extract is incubated with a pool of unlabeled DNA consensus competitors prior to 
adding the labeled DNA probe. An initial EMSA run will determine which cocktail 
competes with the probe binding to nuclear proteins which will then run individually in 
another EMSA to determine the precise competitor (Smith & Humphries, 2008). It is a 
competition-based method to identify uncertain DNA binding proteins requiring only a 
prior knowledge of transcription factor consensus sequences. 
6.4 Two-dimensional EMSA (2D-EMSA) 
The two-dimensional EMSA is a process that combines EMSA with proteomic or sequencing 
techniques to identify the proteins or the nucleic acid sequences that are present in the 
formed complexes. Two slightly different protocols have been developed to identify the 
interacting proteins and another method aims at the target nucleic acid sequence. 
An initial approach was proposed by Woo and colleagues as they tried to identify and 
characterize transcription factors (Woo et al., 2002). A crude nuclear extract is partially 
purified by gel filtration and the resulting fractions are then bound to the nucleic acid probe 
and analyzed by EMSA. Meanwhile, in parallel, the pI and molecular weight of the putative 
interacting protein(s) is estimated as the fractions are analyzed by isoelectric focusing or 
SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) in order to characterize possible 
candidates. Next, spots with the predetermined pI and molecular weight of the candidates 
are excised from a two-dimensional array of nuclear proteins and the proteins are eluted, 
renatured and tested for their binding ability through EMSA and the spots are afterwards 
analyzed by mass spectrometry for protein identification. This method is limited to proteins 
that can re-form into functional nucleic acid-binding conformations after the denaturing 
SDS-PAGE step, although EMSA can still show results even if renaturation efficiency is low. 
Because the final EMSA step that confirms the binding is performed with protein eluted 
from single spots it is only possible to identify proteins that interact with the nucleic acids as 
monomers or homomultimers. Proteins that only interact when complexed with other 
proteins will give a negative result on the validation EMSA. 
A similar 2D-EMSA technique has since then been developed that incorporates EMSA into a 
two-dimensional proteomics approach by replacing the isoelectric focusing with EMSA as 
the first dimension of the 2D method (Stead et al., 2006). The protein sample, in the presence 
or absence of the nucleic acid, is separated by native PAGE as in a conventional EMSA. The 
protein bands from both conditions are then separated in a second dimension by denaturing 
SDS-PAGE. The proteins showing the nucleic acid dependent shift in mobility can be 
extracted from the gel for mass spectrometry identification. This approach does not require 
any previous knowledge of the chemical or physical properties of the binding protein and 
does not require protein renaturation after gel excision. It is also not limited to identify 
proteins that bind by themselves or as homomultimers and allows the characterization of 
complexes composed of different proteins. 
These 2D approaches were developed by the two groups to study transcription factors, 
therefore, double stranded DNA is used as a nucleic acid probe but they can also adapted to 
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other nucleic acid probes making them quite versatile methods to identify nucleic acid-
interacting proteins. 
Chernov and collaborators have developed a similar protocol with two dimensions but 
instead of aiming to identify the interacting protein(s) it characterizes and maps the specific 
protein target sites in regions of the human genome (Chernov et al., 2006). This approach is 
also based on first separating the complexes from the free nucleic acid in a non-denaturing 
gel and afterwards separating it under denaturing conditions (Vetchinova et al., 2006). The 
group used a pool of radioisotope-labeled short DNA sequences covering the genome 
region of interest and mixed it with a nuclear extract from a specific cell line. The formed 
complexes were separated in a non-denaturing one-dimensional standard EMSA.  The 
complexes were localized by autoradiography and the gel strip containing them was excised 
and treated with a denaturing agent, SDS, to disrupt the preformed complexes. The strip is 
then loaded onto the second-dimension denaturing gel and another electrophoresis is 
performed. The gel is autoradiographed to determine the location of the freed DNAs, which 
are afterwards cut from the gel to be analyzed. By pairing this method with high-
throughput sequencing the authors were able to identify a multitude of specific protein 
binding sites within a given genomic region. 
6.5 EMSA-three-dimensional-electrophoresis (EMSA-3DE) 
A three dimensional approach has very recently emerged to purify nucleic acid binding 
proteins from complexes separated by EMSA (Jiang et al., 2011). This method focuses on 
recovering the protein in high yield for subsequent analysis and has been developed to 
study low abundant transcription factors. In this EMSA-based purification procedure the 
complexes formed are extracted after a native PAGE retardation assay and applied to two-
dimensional electrophoresis, isoelectric focusing and SDS-PAGE. The EMSA conditions are 
systematically optimized to reduce non-specific binding and increase protein yield. After 
the three electrophoreses the sample can then be electrotransfered onto a nitrocellulose or 
polyvinylidene difluoride membrane for southwestern and western blotting analysis to 
further characterize the complexes. Spots of interest can be cut from the gel or the 
membrane for protein identification by mass spectrometry. 
7. Alternatives to EMSA 
There are several alternatives to EMSA used in the analysis of nucleic acid-protein 
interactions with its own advantages and disadvantages when compared to EMSA. 
7.1 Footprinting 
Footprinting is essentially a protection assay used to characterize the binding site 
recognized by a given protein. It relies on the fact that a protein bound to the nucleic acid 
will protect it and interfere with the modification of the sequence it is bound to. The 
modification can be chemical or enzymatic and it is usually the endonuclease cleavage of 
radioisotope-labeled nucleic acid previously mixed with the protein(s) of interest. After 
cleavage the resulting ladder is analyzed on denaturing polyacrylamide gel and visualized 
by autoradiography. The gaps in the ladder are indicative of sites protected by the protein 
or proteins in the mixture (reviewed by Hampshire et al., 2007). This method was originally 
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developed to characterize sequence selectivity but it is also helpful in estimating the binding 
strength through a footprinting reaction over a range of protein concentrations. For slow 
binding reactions footprinting can also be applied to assess the reaction kinetics estimating 
the association and dissociation rates. Although it is a widely used method, there are other 
approaches that provide higher throughput as the ones described ahead. 
A variant on DNA footprinting is the in vivo approach, a technique that enables the 
detection of DNA-protein interactions as they occur in the cell. In vivo footprinting also 
relies on the fact that the bound protein protects the nucleic acid, at its binding site, from 
cleavage by endonucleases or modification by a chemical agent. The difference is that the 
cleavage of DNA is carried out within the nucleus following the in vivo binding of the 
proteins to chromatin. Footprints and endonuclease hypersensitive sites that are due to 
deformations of DNA in chromatin can be detected by this in vivo method. This method has 
been coupled with deep sequencing to identify DNaseI hypersensitive sites in the genome of 
different cell lines. It enabled the precise identification of a large number of specific cis-
regulatory protein binding events with a single experiment (Boyle et al., 2011). Accordingly, 
the data obtained by this procedure may be more significant and representative of true 
events when compared with data obtained by the previously described in vitro footprinting.  
7.2 Nitrocellulose filter binding 
Nitrocellulose filter binding assays were developed in the 70s as a rapid enough method to 
allow kinetic as well as equilibrium studies of DNA-protein interactions (Riggs et al., 1968 
and Riggs et al., 1970 as cited in Helwa & Hoheisel, 2010). The manipulation required is 
rapid enough to allow such measurements. The assay is based on the premise that proteins 
can bind to nitrocellulose without losing the ability to bind DNA. After the binding reaction 
the mixture is separated by electrophoresis and then blotted onto a nitrocellulose 
membrane. Only protein bound DNA remains on the membrane as the free double-stranded 
DNA will not be retained on nitrocellulose. The amount of DNA on the membrane can be 
quantified by measuring the label on the nucleic acid. However, this method has its 
limitations such as the fact that the proteins involved are not identified or the proportion in 
which they bind DNA. It also provides no information on the DNA sequence the protein 
interacts with unless well defined nucleic acid fragments are used and is limited to double 
stranded DNA as single stranded DNA can bind to nitrocellulose under certain conditions 
resulting in undesirable background.  
7.3 Microfluidic mobility shift assay (MMSA) 
The capillary microfluidic mobility shift assay (MMSA) is a method that uses fluorescence-
based multi-well capillary electrophoresis to characterize protein-nucleic acid interactions. For 
example, it has been used effectively in characterizing RNA-protein binding in a study of the 
interaction between human immunodeficiency virus 1 transactivator of transcription and the 
transactivation-responsive RNA (Fourtounis et al., 2011). This technique requires only 
nanoliter amounts of sample that are introduced into microscopic channels and separated by 
pressure-driven flow and application of a potential difference. The free molecules or 
complexes are visualized by LED-induced fluorescence, discarding the need for hazardous 
radiolabeling. With the ability to perform 384-well screening this method has an increased 
capacity over regular EMSA to be compatible with high-throughput screenings. 
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7.4 Yeast hybrid systems 
The yeast one-hybrid is an approach used to identify proteins that bind a given nucleic acid 
sequence as opposed to the methods that are suited to identify the nucleic acid sequences 
preferably recognized by a known protein. The protocol is based on a hybrid prey protein 
fused to a transcription activation domain that allows the expression of a reporter gene 
when the prey protein interacts with the DNA bait (reviewed by Deplancke et al., 2004). 
This method allows for a proteome-scale analysis depending on the prey protein library but 
only detects monomers that bind the target nucleic acid. Although it is an in vivo approach it 
is performed in yeast (Saccharomyces cerevisiae), which may not be the endogenous context, 
and is limited to DNA-protein interactions. 
RNA-protein interactions can be studied with a yeast three-hybrid system that involves the 
expression in yeast cells of not one but three chimerical molecules, which assemble in order 
to activate two reporter genes (Kraemer et al., 2000). It represents a modification of the yeast 
two-hybrid system, widely used to identify protein-protein interactions, that was designed 
to allow high sensitivity in vivo detection of RNA-protein interactions. The yeast three-
hybrid system includes: a fusion protein consisting of a DNA binding protein and a RNA-
binding protein; a hybrid protein consisting of a transcription activating domain and a 
peptide thought to interact with a particular RNA; a RNA intermediate that promotes the 
interaction of the two hybrid proteins, this RNA includes the RNA that interacts with the 
system’s RNA-binding protein and the RNA molecule to be investigated. The successful 
interaction of these 3 components allows the reconstitution of a transcription factor and 
subsequent activation of reporter genes (Hook et al., 2005 and Wurster & Maher, 2010) 
7.5 ChiP assays 
Chromatin immunoprecipitation (ChiP) is a commonly used method to study DNA-binding 
proteins in vivo and a standard method for the identification of transcription binding sites 
and histone modification locations (reviewed by Massie & Mills, 2008). In this method a 
cross-linking agent (e.g. formaldehyde) is added to cells to covalently bind proteins and 
chromatin that are in direct contact. Afterwards, the cells are lysed and chromosomal DNA 
is isolated and fragmented. Specific antibodies are used to immunoprecipitate the targeted 
proteins with the cross-linked DNA. The bound nucleic acid is released by reverting the 
cross-linking and then analyzed. Classically, the DNA was characterized by polymerase 
chain reaction (PCR) which required some previous knowledge of the candidate DNA 
regions. Nowadays, the DNA bound to protein is more commonly characterized through 
more powerful tools either coupled with microarrays that represent the genome (ChIP-chip) 
or state-of-the-art high-throughput sequencing (ChIP-seq). The improvements in DNA 
sequencing technology allow tens of millions of sequence reads, therefore ChIP-seq has a 
major advantage of increased sensitivity and resolution to add to the fact that it is not 
limited to predetermined probe sets as ChIP-chip. The major strength of the ChIP-based 
approaches is that they capture complexes in vivo and the binding reactions can be studied 
under different cellular conditions and at different time points. However it also has 
important limitations. The method requires high-quality antibodies that are available only 
for a limited number of proteins. To circumvent this, epitope-tagged proteins could be used 
although it usually implies the introduction of modified genes into the endogenous locus in 
order to obtain expression at physiological levels. This method does not distinguish between 
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proteins that bind directly to the genomic DNA and those that only interact with other 
proteins that do bind.  
7.6 SELEX 
The Systematic Evolution of Ligands by Exponential Enrichment (SELEX) is a well 
established method that enables the selection of enriched sequences from a random library 
that bind recombinant proteins. This procedure starts with the synthesis of the 
oligonucleotide library and then incubating the generated sequences with the putative 
interacting protein(s). The sequences that bind are eluted, amplified by PCR and subjected 
to more rounds of selection with increasing stringency conditions. This allows the 
identification of the tightest-binding sequences. It is a widely used approach to obtain 
transcription factors binding motifs as it requires low amounts of purified proteins (Matys et 
al., 2006). This approach becomes very complicated to use when large numbers of nucleic 
acid-binding proteins are analyzed as it then requires multiple rounds of selection. Another 
limitation is the fact that it is aimed at the identification of the best binding DNA targets in 
vitro and does not allow the characterization of the exact in vivo selectivity. 
7.7 Protein microarray 
A protein microarray is a method that allows high-throughput analysis in which labeled 
nucleic acids are queried against proteins immobilized on a chip (reviewed by Hu et al., 
2011). In a functional protein microarray, thousands of purified recombinant proteins can be 
immobilized in a glass slide in discrete locations forming a high-density protein matrix, 
providing a flexible platform to characterize different protein activities. It is a very versatile 
method as it can perform a semi-quantitative analysis of protein binding to a wide range of 
molecules (nucleic acids, other proteins, antibodies, lipids, glycans…). In theory, it is feasible 
to print arrays of all the annotated proteins of a given organism originating a whole 
proteome microarray. However, it implies the expression and purification of each 
individual protein and several conditions need to be optimized to render the proteins apt 
for this method. Since the protein is immobilized it is crucial to guarantee that its structural 
integrity remains intact especially the binding domains that are to be studied. 
7.8 Nucleic acid microarrays 
Nucleic acid microarrays can also be used for a direct analysis of protein-nucleic acid 
interactions. In this case it is the nucleic acid that is immobilized and not the protein. 
Nucleic acid chips are a powerful and versatile tool in biological research. They consist of 
high-density arrays of oligonucleotides or complementary DNA that can cover a whole 
genome (reviewed by Stoughton, 2005). For protein-interaction studies, the protein(s) of 
interest is expressed usually with an epitope tag, and purified. The tag serves two purposes; 
it helps to isolate the protein through affinity purification, and allows detection by an 
epitope-specific reporter antibody. After incubation of the protein with the nucleic acid chip 
the signal intensities at the several array spots can be measured. 
7.9 Ribonucleoprotein Immunoprecipitation – Microarray (RIP-chip)  
RNA immunoprecipitation and chip hybridization (RIP) is a protocol very similar to ChIP-
chip except that it targets RNA-protein interactions rather than DNA-protein (Keene et al., 
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2006). RIP-chip is an approach that consists on a microarray profiling of RNAs obtained 
from immunoprecipitated RNA-protein complexes. Genome-wide arrays are used to 
identify messenger RNAs (mRNAs) that are present in endogenous messenger 
ribonucleoprotein complexes making it a great tool to identify the physiological substrates 
of mRNAs. The endogenous complexes are immunoprecipitated from cell lysates which 
limits this study to kinetically stable interactions. Even though it can identify RNA-protein 
complexes with heteromultimers, at least one of the proteins has to be previously known to 
be the basis of immunoprecipitation and “fish out” the whole complex. 
7.10 Crosslinking and Immunoprecicipation (CLIP) and Photoactivable-
Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation (PAR-CLIP) 
The RIP-chip method that has just been described is limited to studies of very stable RNA-
protein complexes; to remediate this problem another method is available to study RNA-
binding proteins. The crosslinking and immunoprecipitation (CLIP) approach uses in vivo 
UV crosslinking prior to the complexes immunoprecipitation to identify less stable 
interactions (Ule et al., 2003). After immunoprecipitation RNA molecules are separated and 
cDNA sequencing is carried on. However, this method is not perfect as the commonly used 
UV 254nm RNA-protein crosslinking has low efficiency and it is difficult to distinguish 
between crosslinked RNAs from background non-crosslinked fragments that can be 
detected in the sample due to the presence of abundant cellular RNAs. 
A more recent approach tries to further improve the CLIP method using photoreactive 
ribonucleoside analogs such as 4-thiouridine or 6-thioguanosine (Hafner et al., 2010). In this 
photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-
CLIP) protocol the photoreactive nucleosides are incorporated into nascent transcripts 
within living cells. The irradiation is performed with UV light of 365nm, which induces an 
efficient crosslink of the labeled cellular RNA to its interacting proteins. The labeled RNAs 
are isolated after co-immunoprecipitation, and converted into cDNA for deep sequencing. 
The precise crosslinking position can be identified by mutations in the sequenced cDNA 
making it possible to distinguish the crosslinked fragments from background. 
7.11 High-Throughput Sequencing – Fluorescent Ligand Interaction Profiling  
(HisT-FLIP) 
Very recently a new method was developed to characterize DNA-protein interactions using 
second-generation sequencing instruments (Nutiu et al., 2011). This method allows high 
throughput and quantitative measurement of DNA-protein binding affinity. This High-
Throughput Sequencing – Fluorescent Ligand Interaction Profiling (HiTS-FLIP) uses the 
optics of a high-throughput sequencer to visualize in vitro binding of a protein to the 
sequenced DNA in a flow cell. The new method was initially used on a Saccharomyces 
cerevisiae transcription factor. The fluorescently tagged protein was added at different 
concentrations to a flow cell containing around 88 million DNA clusters, the equivalent of 
over 160 yeast genomes. The traditional EMSA was used as an independent validation of the 
dissociation constants obtained and found a high correlation with values obtained with the 
new method and those from EMSA as reported in literature. This high-throughput method 
has an obvious advantage in the fact that it can provide hundreds of millions of 
measurements but is limited to DNA-protein interactions and requires expensive 
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equipment. Another advantage is that the sequencing instrument can measure multiple 
fluorescent wavelengths allowing hetero and homodimeric forms to be measured in the 
same run, using distinct tags on individual proteins. 
8. Conclusion 
Since the first report, 30 years ago, EMSA became one of the most popular methods for 
detection and characterization of protein-nucleic acid interactions. Hundreds of protocols 
have been published accommodating modifications in virtually every parameter influencing 
the experimental outcome. Improvements were made in all EMSA steps including the 
methods for preparation of protein samples and purification, synthesis and labeling of 
nucleic acids, and detection. This allowed enlarging and diversifying the applications of 
EMSA and resulting in a number of variants of the method.  
However, despite the large amount of available literature and protocols trial and error will 
ultimately be the way to optimize the EMSA conditions for the nucleic acid-protein complex 
to be analyzed. The guidelines discussed above help to provide an initial protocol adjusted 
to each study but slight changes may be needed to improve binding and detection of the 
complexes. 
In recent years, the use of highthrouhput approaches to detect biologically relevant 
interactions, including those between proteins and nucleic acids, was reported. 
Development of these approaches was made possible, at least in part, by the availability of 
more sensitive and specific equipment and tools. Although EMSA cannot achieve a high 
throughput level it remains a valuable tool to confirm the detected interactions. 
9. Acknowledgements 
We are grateful to Dr. Cristina Branco for constructive comments. Work in the authors’ 
laboratory is supported by Fundação para a Ciência e Tecnologia (PTDC/SAU-
MII/098314/2008). CA is a recipient of a FCT PhD grant.  
10. References 
Adachi, Y.; Chen, W.; Shang, W. & Kamata, T. (2005). Development of a direct and sensitive 
detection method for DNA-binding proteins based on electrophoretic mobility shift 
assay and iodoacetamide derivative labelling. Analytical Biochemistry, Vol.342, pp. 
348-351 
Alves, C.; Cheng, H.; Roder, H. & Taylor, J. (2010). Intrinsic disorder and oligomerization of 
the hepatitis delta virus antigen. Virology, Vol. 370, pp 12-21 
Apella, E. & Anderson, C. (2001). Post-translational modifications and activation of p53 by 
genotoxic stresses. European Journal of Biochesmistry, Vol.268, No.10, pp. 2764-2772 
Baneyx, F. (1999). Recombinant protein expression in Escherichia coli. Current Opinion in 
Biotechnology, Vol.10, pp. 411-421 
Boyle, A.; Song, L.; Lee, B.; London, D.; Keefe, D.; Birney, E.; Iyer, V.; Crawford, G. & Furey, 
T. (2011). High-resolution genome-wide in vivo footprinting of diverse 
transcription factors in human cells. Genome Research, Vol.21, No.3, pp. 456-464 
www.intechopen.com
 
Gel Electrophoresis – Advanced Techniques 
 
226 
Chernov, I.; Akopov, S.; Nikolaev, L. & Sverdlov, E. (2006). Identification and mapping of 
DNA binding proteins target sequences in long genomic regions by two-
dimensional  EMSA. BioTechniques, Vol.41, pp. 90-96 
Chi, P.; Van Komen, S.; Sehorn, M.; Sigurdsson, S. & Sung, P. (2006). Roles of ATP binding 
and ATP hydrolysis in human Rad51 recombinase function. DNA Repair, Vol.5, No.3, 
pp. 381–391 
Crothers, D. & Drak, J. (1992). [3] Global features of DNA structure by comparative gel 
electrophoresis. Methods in Enzymology, Vol 212, pp. 46-71 
Demarse, N.; Ponnusamy, S.; Spicer, E.; Apohan, E.; Baatz, J.; Ogretmen, B. & Davies, C. (2009). 
Direct binding of glutharaldehyde 3-phosphate dehydrogenase to telomeric DNA 
protects telomeres against chemotherapy-induced rapid degradation. Journal of 
Molecular Biology, Vol.394, No.4, pp. 789-803 
Deplancke, B.; Dupuy, D.; Vidal, M. & Walhout, A. (2004). A gateway-compatible yeast one-
hybrid system.  Genome Research, Vol.1, 2093-2101 
Dignam, J.; Lebovitz, R. & Roeder, R. (1983). Accurate transcription initiation by RNA 
polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids 
Research, Vol.11, No.5, pp. 1457-1489 
Endo, Y. & Sawasaki, T. (2006). Cell-free expression systems for eukaryotic protein production. 
Current Opinion in Biotechnology, Vol.17, pp. 373-380 
Filion, G.; Fouvry, L. & Defossez, P.-A. (2006). Using reverse electrophoretic mobility shift 
assay to measure an compare protein-DNA binding affinities. Analytical Biochemistry, 
Vol.357, pp. 156-158 
Fourtounis, J.; Falgueyret, J.-P. & Sayegh, C. (2011). Assessing protein-RNA interactions using 
microfluidic capillary mobility shift assays. Analytical Biochemistry, Vol.411, pp. 161-163 
Fried, M. (1989). Measurement of protein-DNA interaction parameters by electrophoresis 
mobility shift assay. Electrophoresis, Vol. 10, pp. 366-376 
Fried, M. & Crothers, D. (1981). Equilibria and kinetics of lac repressor-operator interactions by 
polyacrylamide gel electrophoresis. Nucleic Acid Research, Vol.9, No.23, pp. 6505-6525 
Fried, M. & Crothers, D. (1984). Equilibrium studies of the cyclic AMP receptor protein-
DNA interaction. Journal of Molecular Biology, Vol.172, No.3, pp. 241-262 
Fried, M. & Daugherty, M. (1998). Electrophoretic analysis of multiple protein-DNA 
interactions. Electrophoreis, Vol.19, pp. 1247-1253 
Garner, M. & Revzin, A. (1981). A gel electrophoresis method for quantifying the binding of 
proteins to specific DNA regions: application to components of the Escherichia coli 
lactose operon regulatory system.  Nucleic Acids Research, Vol.9, No.13, pp. 3047-3060 
Goh, A.; Coffil, C. & Lane, D. (2011). The role of mutant p53 in human cancer.  The Journal of 
Pathology, Vol.223, No.2, pp. 116-126 
Granger-Schnarr, M.; Lloubes, R.; de Murcia, G. & Shnarr, M. (1988). Specific protein-DNA 
complexes: immunodetection of the protein component after gel electrophoreis and 
Western blotting. Analytical Biochemistry, Vol.174, No.1, pp. 235-238 
Greco-Stewart, V. & Pelchat, M. (2010). Interaction of host cellular proteins with components 
of the hepatitis delta virus. Viruses, Vol.2, No.1, pp 189-212 
Haffner, M.; Landthaler, M.; Burger, L.; Khorshid, M.; Hausser, J.; Berninger, P.; Rothballer, 
A.; Ascano, M.; Jungkamp, A.-C.; Munschauer, M.; Ulrich, A.; Wardle, G.; Dewell, 
S.; Zavola, M. & Tuschi, T. (2010). PAR-CliP – A method to identify transcriptome-




Electrophoretic Mobility Shift Assay: Analyzing Protein  Nucleic Acid Interactions 
 
227 
Hampshire, A.; Rusling, D.; Broughton-Head, V. & Fox, K. (2007). Footprinting: a method 
for determining the sequence selectivity, affinity and kinetics of DNA-binding 
ligands. Methods, Vol.42, pp. 128-140 
Hellman, L. & Fried, M. (2007). Electrophoretic mobility shift assay (EMSA) for detecting 
protein-nucleic acid interactions. Nature Protocols, Vol.2, No.8, pp. 1849-1861 
Helwa, R. & Hoheisel, J. (2010). Analysis of DNA-protein interactions: from nitrocellulose 
filter binding assays to microarray studies. Analytical & Bioanalytical Chemistry, 
Vol.398, pp. 2551-2561 
Holden, N. & Tacon, C. (2011). Principles and problems of the electrophoretic mobility shift 
assay. Journal of Pharmacological and Toxicological Methods, Vol.63, pp. 7-14 
Hope, I. & Struhl, K. (1987). GCN4, a eukaryotic transcriptional activator protein, binds as a 
dimer to target DNA.  The EMBO Journal, Vol.6, No.9, pp. 2781-2784 
Hook, B.; Bernstein, D.; Zhang, B. & Wickens, M. (2005). RNA-proteins interactions in the 
yeast three-hybrid system: affinity, sensitivity, and enhanced library screening. 
RNA, Vol.11, No.2, pp. 227-233 
Hu, S.; Xie, Z.; Qian, J.; Blackshaws, S. & Zhu, H. (2011). Functional protein microarray 
technology. WIREs Systems Biology and Medicine, Vol.3, pp. 255-268 
Jarvis, D. (2009). Baculovirus-insect cell expression systems. Methods in Enzymology, Vol.463, 
pp. 191-222 
Jiang, D.; Jia, Y. & Jarrett, H.W. (2011). Transcription factor proteomics: Identification by a 
novel gel mobility shift-three-dimensional electrophoresis method coupled with 
southwestern blot and high-performance liquid chromatography-electrospray-mass 
spectrometry analysis. Journal of Chromatography A, Vol.1218, No.39, pp. 7003-7015 
Jiang, S.; Macias, M. & Jarrett, H. (2010). Purification and identification of a transcription 
factor, USF2, binding to E-box elements in the promoter of human telomerase 
reverse transcriptase (hTERT). Proteomics, Vol.10, No.2, pp. 203-211 
Jimenez, J. (2010). Protein-DNA interaction at the origin of neurological diseases: a 
hypothesis. Journal of Alzheimer’s Disease, Vol.22, No.2, pp. 375-391 
Keene, J.; Komisarow, J. & Friedersdorf, M. (2006). RIP-Chip: the isolation and identification 
of mRNAs, microRNAs and protein components of ribonucleoprotein complexes 
from cell extracts. Nature Protocols, Vol.1, pp. 302-307 
Kerr, L. (1995). [42] Electrophoretic mobility shift assay. Methods in Enzymology, Vol.254, pp. 
619-632 
Kraemer, B.; Zhang, B.; SenGupta, D.; Fields, S. & Wickens, M. (2000). Using the yeast three-
hybrid system to detect and analyze RNA-protein interactions. Methods in 
Enzymology, Vol.328, pp. 297-321 
Lane, D.; Prentki, P. & Chandler, M. (1992). Use of gel retardation to analyze protein-nucleic 
acid interactions. Microbiological Reviews, Vol.56, No.4, pp. 509-528 
Makino, T.; Skretas, G. & Georgiou, G. (2011). Strain engeneering for improved expression 
of recombinant proteins in bacteria. Microbial Cell Factories, Vol.10, No.1, pp. 32-42 
Massie, C. & Mills, I. (2008). ChIPping away at gene regulation. EMBO Reports, Vol.9, No.4, 
pp. 337-343 
Matys, V.; Kel-Margoulis, O.; Fricke, E.; Liebich, I.; Land, S.; Barre-Dirrie, A.; Reuter, I.; 
Checkmenev, D.; Krull, M.; Hornischer, K.; Voss, N.; Stegmaier, P.; Lewicki-
Potapov, B.; Saxel, H.; Kel, A. & Wingender, E. (2006). TRANSFAC and its module 
TRANSComple: transcriptional gene regulation in eukaryotes. Nucleic Acids 
Research, 1 34 Database issue D108-110 
www.intechopen.com
 
Gel Electrophoresis – Advanced Techniques 
 
228 
Nordheim, A. & Meese, K. (1988). Topoisomer gel retardation: detection of anti-Z-DNA 
antibodies bound to Z-DNA within supercoiled DNA minicircles. Nucleic Acids 
Research, Vol.16, No.1, pp. 21-37 
Nutiu, R.; Friedman, R.; Luo, S.; Khrebtukova, I.; Silva, D.; Li, R.; Zhang, L.; Schroth, G. & 
Burge, C. (2011). Direct measurement of DNA affinity landscapes on a high-
throughput sequencing instrument. Nature Biotechnology, Vol.29, No.7, pp. 659-664 
Palecek, E.; Vlk, D.; Stankova, V.; Brazda, V.; Vojtesek, B.; Hupp, T.; Schaper, A. & Jovin, T. 
(1997). Tumor suppressor protein p53 binds preferentially to supercoiled DNA. 
Oncogene, Vol.15, No.18, pp. 2201-2209 
Puzio-Kuter, A. (2011). The role of p53 in metabolic regulation. Genes & Cancer, Vol.2, No.4, 
pp. 385-391 
Rizzetto, M. (2009). Hepatitis D: Thirty years after. Journal of Hepatology, Vol.50, pp. 1043-1050 
Ruscher, K.; Reuter, M.; Kupper, D.; Trendelenburg, G.; Dirnagl, U. & Meisel, A. (2000). A 
fluorescence based non-radioactive electrophoretic mobility shift assay. Journal of 
Biotechnology, Vol78, pp. 163-170 
Saida, F.; Uzan, M.; Odaert, B. & Bontems, F. (2006). Expression of highly toxic genes in E. coli: 
special strategies and genetic tools. Current Protein and Peptide Science, Vol.7, pp. 47-56 
Sandman, K.; Krzycki, J.; Dobrinski, B.; Lurz, R. & Reeve, J. (1990). HMf, a DNA-binding 
protein isolated from the hyperthermophilic archaeon Methanothermus fervidus, is 
most closely related to histone. Proceedings of the National Academy of Sciences of the 
United States of America, Vol.87, No.15, pp. 5788-5791 
Simicevic, J. & Deplancke, B. (2010). DNA-centered approaches to characterize regulatory 
protein-DNA interaction complexes. Molecular BioSystems, Vol.6, No.3, pp. 462-468 
Spinner, D.; Liu, S.; Wang, S-W. & Schmidt, J. (2002). Interaction of the myogenic 
determination factor myogenin with E12 and a DNA target: mechanism and 
kinetics. Journal of Molecular Biology, Vol.317, No.3, pp. 431-445 
Stead, J.; Keen, J. & McDowall, K. (2006). The identification of nucleic acid-interacting proteins 
using a simple proteomics-based approach that directly incorporates the electrophoretic 
mobility shift assay. Molecular & Cellular Proteomics, Vol.5, No.9, pp. 1697-1702 
Stoughton, R. (2005). Applications of DNA microarrays in biology. Annual Review of 
Biochemistry, Vol.74, pp. 53-82 
Ule, J.; Jensen, K.; Ruggiu, M.; Mele, A.; Ule, A. & Darnell, R. (2003). CLIP identifies Nova-
regulated RNA networks in the brain. Science, Vol.302, No.5648, pp. 1212-1215 
Vetchinova, A.; Akopov, S.; Chernov, I.; Nikolaev, L. & Sverdlov, E. (2006). Two-
dimensional electrophoretic mobility shift assay: identification and mapping of 
transcription factor CTCF target sequences within an FXYD5-COX7A1 region of 
human chromosome 19. Analytical Biochemistry, Vol.354, pp. 85-93 
Vossen, K.; Wolz, R.; Daugherty, M. & Fried, M. (1997). Role of macromolecular hydration in 
the binding of the Escherichia coli cyclic AMP receptor to DNA. Biochemistry, 
Vol.36, No.39, pp. 11640-11647 
Walker, J. (1994). Gradient SDS polyacrylamide gel electrophoresis of proteins. Methods in 
Molecular Biology, Vol.32, pp. 35-38 
Woo, A.; Dods, J.; Susanto, E.; Ulgiati, D. & Abraham, L. (2002). A proteomics approach for 
the identification of DNA binding activities observed in the electrophoretic 
mobility shift assay. Molecular & Cellular Proteomics, Vol.1, No.6, pp. 472-478 
Wurster, S. & Maher, L. (2010). Selections that optimize RNA display in the yeast three-
hybrid system. RNA, Vol.16, No.2, pp. 253-258 
www.intechopen.com
Gel Electrophoresis - Advanced Techniques
Edited by Dr. Sameh Magdeldin
ISBN 978-953-51-0457-5
Hard cover, 500 pages
Publisher InTech
Published online 04, April, 2012
Published in print edition April, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
As a basic concept, gel electrophoresis is a biotechnology technique in which macromolecules such as DNA,
RNA or protein are fractionated according to their physical properties such as molecular weight or charge.
These molecules are forced through a porous gel matrix under electric field enabling uncounted applications
and uses. Delivered between your hands, a second book of this Gel electrophoresis series (Gel
Electrophoresis- Advanced Techniques) covers a part, but not all, applications of this versatile technique in
both medical and life science fields. We try to keep the contents of the book crisp and comprehensive, and
hope that it will receive overwhelming interest and deliver benefits and valuable information to the readers.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Carolina Alves and Celso Cunha (2012). Electrophoretic Mobility Shift Assay: Analyzing Protein - Nucleic Acid
Interactions, Gel Electrophoresis - Advanced Techniques, Dr. Sameh Magdeldin (Ed.), ISBN: 978-953-51-
0457-5, InTech, Available from: http://www.intechopen.com/books/gel-electrophoresis-advanced-
techniques/electrophoretic-mobility-shift-assay-analyzing-protein-nucleic-acid-interactions
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
